TOP STORIES
Endo just announced this morning it will acquire Par Pharmaceutical for $8.05 billion – a shakeup in the generics industry.
MIT does a nice job outlining what it’s doing in single-cell genomics, “to study individual cells at a speed and scale previously unthinkable.”
LIFE SCIENCE
Veracyte’s Percepta Bronchial Genomic Classifier diagnostic delivered strong news about its ability to help people avoid invasive lung biopsies.
Boehringer Ingelheim exercised its option to buy Pharmaxis’ Phase 1 anti-inflammatory drug to treat steatohepatitis and COPD
Abcodia raised $8.25 million through by Cambridge Innovation Capital and Scottish Equity Partners to develop cancer-detection tests.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Astellas Pharma reported good news from its Phase 3b BESIDE clinical trial.
PAYERS-PROVIDERS
The American Journal of Managed Care is getting louder on healthcare reform: a new online contributor forum will focus on issues that matter to payers.
What do you know? Medical residents make people happy – even surgeons.
Partners Healthcare: Innovative but still struggling financially.
TECH
Healthcare had the fourth-largest early-stage tech deal in April: Honor Technology ($20 million).
Agree? “There are just too many damn apps.”
A LITTLE EXTRA
Here it is: the trailer for the new Steve Jobs movie.
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.
Photo: Wikimedia Commons
